Share on LinkedInShare on LinkedIn

ARTICLE · 27 OCTOBER 2025

FDA Tightens Direct-to-Consumer Pharmaceutical Advertising In The US

Cassels
Cassels
Contributor
Cassels

Cassels

Cassels Brock & Blackwell LLP is a Canadian law firm focused on serving the transaction, advocacy,...

View firm profile
Explore more from Cassels

On September 9, 2025, the US Food and Drug Administration (FDA) launched one of its most aggressive and comprehensive enforcement initiatives in decades...

CanadaMedia, Telecoms, IT, Entertainment

On September 9, 2025, the US Food and Drug Administration (FDA) launched one of its most aggressive and comprehensive enforcement initiatives in decades, targeting deceptive pharmaceutical advertising practices across television, digital platforms, and social media.

The FDA's shift toward greater transparency and proactive enforcement marks a turning point in US pharmaceutical regulation. For Canadian regulators, marketers, and policymakers, this development raises questions about the adequacy of domestic oversight, particularly as cross-border exposure increases, and evolving advertising formats test the limits of Canada's current regulatory framework.

FDA Enforcement Shift

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from